MRI Biomarkers and Neuropsychological Assessments of Hippocampal and Parahippocampal Regions Affected by ALS: A systematic Review

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2024 Feb 9

PMID 38334254

Authors

Sana Mohammadi

Sadegh Ghaderi

Farzad Fatehi

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Amyotrophic lateral sclerosis (ALS) is a progressive motor and extra-motor neurodegenerative disease. This systematic review aimed to examine MRI biomarkers and neuropsychological assessments of the hippocampal and parahippocampal regions in patients with ALS.

Methods: A systematic review was conducted in the Scopus and PubMed databases for studies published between January 2000 and July 2023. The inclusion criteria were (1) MRI studies to assess hippocampal and parahippocampal regions in ALS patients, and (2) studies reporting neuropsychological data in patients with ALS.

Results: A total of 46 studies were included. Structural MRI revealed hippocampal atrophy, especially in ALS-FTD, involving specific subregions (CA1, dentate gyrus). Disease progression and genetic factors impacted atrophy patterns. Diffusion tensor imaging (DTI) showed increased mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD), and decreased fractional anisotropy (FA) in the hippocampal tracts and adjacent regions, indicating loss of neuronal and white matter integrity. Functional MRI (fMRI) revealed reduced functional connectivity (FC) between the hippocampus, parahippocampus, and other regions, suggesting disrupted networks. Perfusion MRI showed hypoperfusion in parahippocampal gyri. Magnetic resonance spectroscopy (MRS) found changes in the hippocampus, indicating neuronal loss. Neuropsychological tests showed associations between poorer memory and hippocampal atrophy or connectivity changes. CA1-2, dentate gyrus, and fimbria atrophy were correlated with worse memory.

Conclusions: The hippocampus and the connected regions are involved in ALS. Hippocampal atrophy disrupted connectivity and metabolite changes correlate with cognitive and functional decline. Specific subregions can be particularly affected. The hippocampus is a potential biomarker for disease monitoring and prognosis.

Citing Articles

Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis.

Tan H, Nitert A, van Veenhuijzen K, Dukic S, van Zandvoort M, Hendrikse J Neuroimage Clin. 2025; 45:103749.

PMID: 39947099 PMC: 11869911. DOI: 10.1016/j.nicl.2025.103749.

Neural correlates of basketball proficiency: An MRI study across skill levels.

Zhang M, Zhang W, Yao Y, Lin J, Mo L J Exerc Sci Fit. 2024; 23(1):14-20.

PMID: 39737438 PMC: 11683229. DOI: 10.1016/j.jesf.2024.12.001.

Involvement of the left uncinate fasciculus in the amyotrophic lateral sclerosis: an exploratory longitudinal multi-modal neuroimaging and neuropsychological study.

Ghaderi S, Fatehi F, Kalra S, Mohammadi S, Batouli S Brain Struct Funct. 2024; 230(1):8.

PMID: 39688717 DOI: 10.1007/s00429-024-02884-3.

Diffusion tensor imaging biomarkers and clinical assessments in amyotrophic lateral sclerosis (ALS) patients: an exploratory study.

Pezeshgi S, Ghaderi S, Mohammadi S, Karimi N, Ziaadini B, Mohammadi M Ann Med Surg (Lond). 2024; 86(9):5080-5090.

PMID: 39239063 PMC: 11374192. DOI: 10.1097/MS9.0000000000002332.

Volume loss in the left anterior-superior subunit of the hypothalamus in amyotrophic lateral sclerosis.

Ghaderi S, Fatehi F, Kalra S, Mohammadi S, Zemorshidi F, Ramezani M CNS Neurosci Ther. 2024; 30(6):e14801.

PMID: 38887187 PMC: 11183167. DOI: 10.1111/cns.14801.

References

Cenquizca L, Swanson L . Spatial organization of direct hippocampal field CA1 axonal projections to the rest of the cerebral cortex. Brain Res Rev. 2007; 56(1):1-26. PMC: 2171036. DOI: 10.1016/j.brainresrev.2007.05.002. View

Mioshi E, Lillo P, Yew B, Hsieh S, Savage S, Hodges J . Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013; 80(12):1117-23. DOI: 10.1212/WNL.0b013e31828869da. View

Ghaderi S, Batouli S, Mohammadi S, Fatehi F . Iron quantification in basal ganglia using quantitative susceptibility mapping in a patient with ALS: a case report and literature review. Front Neurosci. 2023; 17:1229082. PMC: 10593460. DOI: 10.3389/fnins.2023.1229082. View

Ferraro P, Cabona C, Meo G, Rolla-Bigliani C, Castellan L, Pardini M . Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis. Neuroradiology. 2021; 63(9):1481-1487. DOI: 10.1007/s00234-021-02681-3. View

Bede P, Omer T, Finegan E, Chipika R, Iyer P, Doherty M . Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018; 12(6):1696-1707. DOI: 10.1007/s11682-018-9837-9. View

McAlary L, Chew Y, Lum J, Geraghty N, Yerbury J, Cashman N . Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises. Front Cell Neurosci. 2020; 14:581907. PMC: 7671971. DOI: 10.3389/fncel.2020.581907. View

Mohammadi S, Ghaderi S, Fatehi F . MRI biomarkers and neuropsychological assessments of hippocampal and parahippocampal regions affected by ALS: A systematic review. CNS Neurosci Ther. 2024; 30(2):e14578. PMC: 10853901. DOI: 10.1111/cns.14578. View

Cherubini E, Miles R . The CA3 region of the hippocampus: how is it? What is it for? How does it do it?. Front Cell Neurosci. 2015; 9:19. PMC: 4318343. DOI: 10.3389/fncel.2015.00019. View

Rule R, Schuff N, Miller R, Weiner M . Gray matter perfusion correlates with disease severity in ALS. Neurology. 2010; 74(10):821-7. PMC: 2839193. DOI: 10.1212/WNL.0b013e3181d3e2dd. View

10.

Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S . Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015; 85(15):1301-9. DOI: 10.1212/WNL.0000000000002017. View

11.

Rajagopalan V, Pioro E . Graph theory network analysis provides brain MRI evidence of a partial continuum of neurodegeneration in patients with UMN-predominant ALS and ALS-FTD. Neuroimage Clin. 2022; 35:103037. PMC: 9123271. DOI: 10.1016/j.nicl.2022.103037. View

12.

Soni N, Srindharan K, Kumar S, Mishra P, Bathla G, Kalita J . Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions. Neuroradiol J. 2018; 31(6):544-553. PMC: 6243465. DOI: 10.1177/1971400918783058. View

13.

Reitz C, Brickman A, Brown T, Manly J, DeCarli C, Small S . Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol. 2009; 66(11):1385-92. PMC: 2778802. DOI: 10.1001/archneurol.2009.214. View

14.

Mazon M, Vazquez Costa J, Ten-Esteve A, Marti-Bonmati L . Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis. Front Neurosci. 2018; 12:784. PMC: 6209630. DOI: 10.3389/fnins.2018.00784. View

15.

Manzo E, Lorenzini I, Barrameda D, OConner A, Barrows J, Starr A . Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife. 2019; 8. PMC: 6557627. DOI: 10.7554/eLife.45114. View

16.

Christidi F, Karavasilis E, Rentzos M, Velonakis G, Zouvelou V, Xirou S . Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections. Neurobiol Aging. 2019; 84:178-188. DOI: 10.1016/j.neurobiolaging.2019.07.019. View

17.

Ferrari R, Manzoni C, Hardy J . Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues. Neurobiol Aging. 2019; 78:98-110. DOI: 10.1016/j.neurobiolaging.2019.02.006. View

18.

Eichenbaum H, Lipton P . Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus. 2008; 18(12):1314-24. PMC: 2592493. DOI: 10.1002/hipo.20500. View

19.

Rusina R, Vandenberghe R, Bruffaerts R . Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement. Diagnostics (Basel). 2021; 11(4). PMC: 8065866. DOI: 10.3390/diagnostics11040624. View

20.

Singh Anand K, Dhikav V . Hippocampus in health and disease: An overview. Ann Indian Acad Neurol. 2013; 15(4):239-46. PMC: 3548359. DOI: 10.4103/0972-2327.104323. View